These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20375427

  • 1. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
    Klopfleisch R, Klose P, Gruber AD.
    Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R, Gruber AD.
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [Abstract] [Full Text] [Related]

  • 3. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R, Gruber AD.
    J Comp Pathol; 2009 May; 141(2-3):113-20. PubMed ID: 19515379
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH, Kim WH, Lim JH, Kang MS, Kim DY, Kweon OK.
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
    Klopfleisch R, Klose P, Weise C, Bondzio A, Multhaup G, Einspanier R, Gruber AD.
    J Proteome Res; 2010 Dec 03; 9(12):6380-91. PubMed ID: 20932060
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A, Alves A, Schmitt F.
    Vet J; 2010 Apr 03; 184(1):45-51. PubMed ID: 19264518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC, Tsai MH, Liao JW, Chan JP, Wong ML, Chang SC.
    J Am Vet Med Assoc; 2009 Aug 15; 235(4):391-6. PubMed ID: 19681719
    [Abstract] [Full Text] [Related]

  • 18. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM, Millán Y, Dios R.
    Vet Pathol; 2005 Mar 15; 42(2):200-12. PubMed ID: 15753474
    [Abstract] [Full Text] [Related]

  • 19. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R, Schütze M, Gruber AD.
    Vet Pathol; 2010 Jan 15; 47(1):98-101. PubMed ID: 20080488
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.